I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fast Company has named Eascra Biotech, a nanomedicine startup, to its annual Next ...

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

Below are ten living figures whose ideas are already changing the world—or could define the next era, along with a relevant ...

Joel Mokyr, Philippe Aghion and Peter Howitt won the prize for showing how “society must keep an eye on the factors that ...

Bristol Myers Squibb is pivoting from small-molecule drugs to mRNA and gene therapies. Click here to read more about BMY ...

The collaboration is backed by up to €95 million in blended financing, comprising a €35 million grant from the European ...

BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission: ...

Breakthrough technology that transforms the body into a virus-zapping vaccine factory is poised to revolutionise the fight against COVID-19 but future pandemics and even cancer could be next, ...

With support from the National Institutes of Health, the COBRE Center for RNA Biology in Health and Disease will create a ...